Discover
ALXO
ALX Oncology Holdings Inc.
1.97
8 x 1.97
21 x 1.98
bid
ask
-
0.09
4.37%
12:37 PM
timesize
| Ytd | 74.34% | |
| 1y | 220.33% |
1.96
day range
2.08
0.60
52 week range
2.66
| Open | 2.08 | Prev Close | 2.06 | Low | 1.96 | High | 2.08 | Mkt Cap | 265.76M |
| Vol | 221.30K | Avg Vol | 1.38M | EPS | -1.13 | P/E | -1.75 | Forward P/E | -0.68 |
| Beta | 0.42 | Short Ratio | 8.58 | Inst. Own | 88.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-08 | 50-d Avg | 1.89 | 200-d Avg | 1.77 | 1yr Est | 7.67 |
| Income Statement | |||
| Operating Expenses | 18.03M | ||
| Research and Development Expense | 13.14M | ||
| Selling, General and Administrative Expense | 5.13M | ||
| Operating Income | -18.03M | ||
| Interest Expense | 285.00K | ||
| Net Income | -17.97M | ||
| Net Income Common Stock | -17.97M | ||
| Net Income Common Stock (USD) | -17.97M | ||
| Consolidated Income | -17.97M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -17.69M | ||
| Earning Before Interest & Taxes (USD) | -17.69M | ||
| Weighted Average Shares | 135.64M | ||
| Weighted Average Shares Diluted | 135.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.69M | ||
| Cash and Equivalents (USD) | 22.69M | ||
| Investments | 130.69M | ||
| Investments Current | 115.54M | ||
| Investments Non-Current | 15.15M | ||
| Current Assets | 143.46M | ||
| Property, Plant & Equipment Net | 166.00K | ||
| Total Assets | 160.82M | ||
| Total Debt | 9.71M | ||
| Current Liabilities | 14.78M | ||
| Debt Non-Current | 9.71M | ||
| Total Liabilities | 24.63M | ||
| Accumulated Retained Earnings (Deficit) | -758.71M | ||
| Accumulated Other Comprehensive Income | -224.00K | ||
| Shareholders Equity | 136.19M | ||
| Shareholders Equity (USD) | 136.19M | ||
| Assets Non-Current | 17.36M | ||
| Total Debt (USD) | 9.71M | ||
| Liabilities Non-Current | 9.86M | ||
| Trade and Non-Trade Payables | 3.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 86.00K | ||
| Net Cash Flow from Financing | 137.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.40M | ||
| Capital Expenditure | 27.00K | ||
| Issuance (Purchase) of Equity Shares | -46.00K | ||
| Issuance (Repayment) of Debt Securities | 180.00K | ||
| Net Cash Flow from Investing | 6.52M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.50M | ||
| Net Cash Flow from Operations | -16.06M | ||
| Share Based Compensation | 2.68M | ||